Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Routine droperidol pre-medication improves sedation for ERCP.

R T Wille1, J L Barnett, W D Chey

  • 1Division of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.

Gastrointestinal Endoscopy
|September 1, 2000
PubMed
Summary

Droperidol pre-medication significantly improved patient and physician satisfaction with sedation during endoscopic retrograde cholangiopancreatography (ERCP). This approach also reduced post-procedure nausea and vomiting without increasing costs or recovery time.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radar plots: A novel modality for displaying disparate data on the efficacy of eluxadoline for the treatment of irritable bowel syndrome with diarrhea.

Neurogastroenterology and motility·2018
Same author

Editorial: recurrence of Helicobacter pylori infection-still the same after all these years….

Alimentary pharmacology & therapeutics·2017
Same author

Development and validation of the Patient-Physician Relationship Scale among patients with irritable bowel syndrome.

Neurogastroenterology and motility·2017
Same author

Early response predicts a sustained response to eluxadoline in patients with irritable bowel syndrome with diarrhoea in two Phase 3 studies.

Alimentary pharmacology & therapeutics·2017
Same author

Effects of baseline abdominal pain and bloating on response to lubiprostone in patients with irritable bowel syndrome with constipation.

Alimentary pharmacology & therapeutics·2016
Same author

Rome IV. Gallbladder and Sphincter of Oddi Disorders.

Gastroenterology·2016

Area of Science:

  • Gastroenterology
  • Anesthesiology
  • Clinical Pharmacology

Background:

  • Droperidol is a potential pre-medication for improving sedation during endoscopic procedures.
  • Its efficacy in enhancing patient and physician satisfaction during ERCP requires investigation.

Purpose of the Study:

  • To evaluate the effectiveness of routine droperidol pre-medication in improving sedation quality during ERCP.
  • To assess patient and physician satisfaction with sedation in ERCP patients.

Main Methods:

  • A double-blind, placebo-controlled study involving 67 patients undergoing ERCP.
  • Patients received either droperidol (5 mg) or normal saline placebo intravenously 15 minutes prior to the procedure.
  • Sedation parameters were scored by the endoscopist, nurse, and patient; a 24-hour follow-up call was also conducted.

Related Experiment Videos

Main Results:

  • Droperidol significantly reduced gagging, retching, and post-procedure nausea/vomiting.
  • Physician, nurse, and patient satisfaction with sedation was significantly improved with droperidol.
  • Reduced need for physical restraint and increased patient amnesia were observed with droperidol.

Conclusions:

  • Routine droperidol pre-medication enhances overall satisfaction with sedation during ERCP.
  • It effectively mitigates adverse effects like nausea and vomiting without compromising recovery time or cost.
  • Droperidol is recommended for routine use in pre-ERCP sedation protocols.